|
|
Brian J. Druker, Nicholas B. Lydon
J Clin Invest. 2000;
105(1):3
doi:10.1172/JCI9083
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(41)
| Title and authors |
Publication |
Year |
Therapeutic inhibition of the Janus kinases
Arian Laurence, Kamran Ghoreschi, Kiyoshi Hirahara, Xiangping Yang, John J. O'Shea
|
Inflammation and Regeneration
|
2012 |
Hurdles in anticancer drug development from a regulatory perspective
Bertil Jonsson, Jonas Bergh
|
Nat Rev Clin Oncol
|
2012 |
Perspectives on personalized cancer care
Garrett M. Dancik, Dan Theodorescu
|
Urol Oncol Semin Orig Invest
|
2012 |
Are breast cancers driven by fusion genes?
Paul AW Edwards, Karen D Howarth
|
Breast Cancer Res
|
2012 |
Treatment options for chronic myeloid leukemia
Maria Florencia Tanaka, Hagop Kantarjian, Jorge Cortes, Maro Ohanian, Elias Jabbour
|
Expert Opin. Pharmacother.
|
2012 |
FMSKinase Inhibitors: Current Status and Future Prospects : FMS KINASE INHIBITORS
Mohammed I. El-Gamal, Hanan S. Anbar, Kyung Ho Yoo, Chang-Hyun Oh
|
Med. Res. Rev.
|
2012 |
Single-Molecule Recognition of Biomolecular Interaction <i>via</i> Kelvin Probe Force Microscopy
Jinsung Park, Jaemoon Yang, Gyudo Lee, Chang Young Lee, Sungsoo Na, Sang Woo Lee, Seungjoo Haam, Yong-Min Huh, Dae Sung Yoon, Kilho Eom
|
ACS Nano
|
2011 |
Current opinions and controversies in chronic myeloid leukaemia :
Bhuvan Kishore, David Marin
|
Current Opinion in Oncology
|
2011 |
Tyrosine kinase inhibitor resistance in chronic myeloid leukemia cell lines: investigating resistance pathways
Carine Tang, Lisa Schafranek, Dale B. Watkins, Wendy T. Parker, Sarah Moore, Jodi A. Prime, Deborah L. White, Timothy P. Hughes
|
Leukemia & Lymphoma
|
2011 |
Tyrosine kinase inhibitor therapy for systemic sclerosis: Quo Vadis?
Fabian A. Mendoza, Sergio A. Jiménez
|
Arthritis Rheum
|
2011 |
|